AMEX · ITDD
iShares LifePath Target Date 2040 ETF
$38.16-$0.43 (-1.11%)
iShares LifePath Target Date 2040 ETF’s quoted price sits in the upper half of its reported 52-week range, 3.32% below the high.
Loading market information…
NASDAQ · HRTS · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Tema Heart & Health ETF’s quoted price sits in the upper half of its reported 52-week range, 0.4% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Tema Heart & Health ETF’s forward annual dividend is $0.47 per share, paid annual. The forward yield is 1.22% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE COMPANY BEHIND THE TICKER
The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries. Its investment mandate specifically targets firms focused on advancing treatments and therapies for cardiovascular health, metabolic disorders, and weight management.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 03:53 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$38.16-$0.43 (-1.11%)
iShares LifePath Target Date 2040 ETF’s quoted price sits in the upper half of its reported 52-week range, 3.32% below the high.
$44.88-$0.78 (-1.72%)
Affinity World Leaders Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 8.68% below the high.
$112.21-$2.01 (-1.76%)
Invesco Dorsey Wright Basic Materials Momentum ETF’s quoted price sits in the lower half of its reported 52-week range, 16.32% below the high.
$154.97-$0.38 (-0.25%)
AdvisorShares Insider Advantage ETF’s quoted price sits in the upper half of its reported 52-week range, 0.55% below the high.
$44.82-$0.32 (-0.71%)
Strive Natural Resources and Security ETF’s quoted price sits in the upper half of its reported 52-week range, 9.76% below the high.
$26.60+$0.18 (+0.69%)
Global X - India Active ETF’s quoted price sits in the lower half of its reported 52-week range, 12.57% below the high.
$29.98-$0.46 (-1.51%)
American Beacon Select Funds - Ahl Liquid Trend ETF’s quoted price sits in the upper half of its reported 52-week range, 7.41% below the high.
$44.13+$0.16 (+0.36%)
Invesco Dorsey Wright Utilities Momentum ETF’s quoted price sits in the lower half of its reported 52-week range, 9.77% below the high.
